Join Growin Stock Community!

Cdt equity inc.CDTTW.US Overview

US StockHealthcare
(No presentation for CDTTW)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CDTTW AI Insights

CDTTW Overall Performance

CDTTW AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CDTTW Recent Performance

-16.05%

Cdt equity inc.

0.05%

Avg of Sector

-0.31%

S&P500

CDTTW PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CDTTW Key Information

CDTTW Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CDTTW Profile

Conduit Pharmaceuticals Limited operates as a clinical stage specialty biopharmaceutical company that provides unmet medical needs in the areas of autoimmune disease and idiopathic male infertility. The company was incorporated in 2022 and is based in Grand Cayman, Cayman Islands.Conduit Pharmaceuticals Limited operates as a subsidiary of Corvus Capital Limited.

Price of CDTTW

CDTTW FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CDTTW Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-11.76
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
33.05%
Net Margin
-0.64%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-11.76
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
-
PB Ratio
-
Price-to-FCF
-
Gross Margin
33.05%
Net Margin
-0.64%
Revenue Growth (YoY)
-%
Profit Growth (YoY)
-%
3-Year Revenue Growth
-%
3-Year Profit Growth
-%
  • When is CDTTW's latest earnings report released?

    The most recent financial report for Cdt equity inc. (CDTTW) covers the period of 2025Q1 and was published on 2025/03/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CDTTW's short-term business performance and financial health. For the latest updates on CDTTW's earnings releases, visit this page regularly.

  • What is the operating profit of CDTTW?

    According to the latest financial report, Cdt equity inc. (CDTTW) reported an Operating Profit of -4.01M with an Operating Margin of -0.64% this period, representing a decline of 35.67% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CDTTW's revenue growth?

    In the latest financial report, Cdt equity inc. (CDTTW) announced revenue of 624.86M, with a Year-Over-Year growth rate of 16.65%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does CDTTW have?

    At the end of the period, Cdt equity inc. (CDTTW) held Total Cash and Cash Equivalents of 3.33M, accounting for 0.42 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CDTTW go with three margins increasing?

    In the latest report, Cdt equity inc. (CDTTW) did not achieve the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of -0.53%%, and net margin of -0.36%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CDTTW's profit trajectory and future growth potential.

  • Is CDTTW's EPS continuing to grow?

    According to the past four quarterly reports, Cdt equity inc. (CDTTW)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 1.29. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CDTTW?

    Cdt equity inc. (CDTTW)'s Free Cash Flow (FCF) for the period is -24.76M, calculated as Operating Cash Flow minus Capital Expenditures, representing a rise of 6.94% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of CDTTW?

    The latest valuation data shows Cdt equity inc. (CDTTW) has a Price-To-Earnings (PE) ratio of -29.01 and a Price/Earnings-To-Growth (PEG) ratio of 0.15. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.